BioNTech (NASDAQ: BNTX) CEO Uğur Şahin thinks that new COVID-19 vaccines could be needed by the middle of 2022. In this Motley Fool Live video recorded on Oct. 6, Motley Fool contributors Keith Speights and Brian Orelli discuss Şahin’s reasoning and how vaccine stocks could be affected if he’s right.